Variant | Gene | Disease | Risk Allele | Score vda | Association Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
A | 0.710 | GeneticVariation | CLINVAR | Prospective enterprise-level molecular genotyping of a cohort of cancer patients. | 25157968 | 2014 |
|||||||
|
|
T | 0.710 | CausalMutation | CLINVAR | Prospective enterprise-level molecular genotyping of a cohort of cancer patients. | 25157968 | 2014 |
|||||||
|
|
G | 0.710 | GeneticVariation | CLINVAR | Prospective enterprise-level molecular genotyping of a cohort of cancer patients. | 25157968 | 2014 |
|||||||
|
|
T | 0.710 | CausalMutation | CLINVAR | Molecular characterization of acquired resistance to the BRAF inhibitor dabrafenib in a patient with BRAF-mutant non-small-cell lung cancer. | 23524406 | 2013 |
|||||||
|
|
0.710 | GeneticVariation | BEFREE | V600R mutation and double (V600E -V600M) mutation were identified in two melanomas.In one case, V600K mutation was found.Two screening failures were noted. | 23463675 | 2013 |
||||||||
|
|
T | 0.710 | CausalMutation | CLINVAR | Clinical, pathologic, and biologic features associated with BRAF mutations in non-small cell lung cancer. | 23833300 | 2013 |
|||||||
|
|
T | 0.710 | CausalMutation | CLINVAR | Overwhelming response to Dabrafenib in a patient with double BRAF mutation (V600E; V600M) metastatic malignant melanoma. | 23031422 | 2012 |
|||||||
|
|
T | 0.710 | CausalMutation | CLINVAR | A patient with BRAF V600E lung adenocarcinoma responding to vemurafenib. | 22743296 | 2012 |
|||||||
|
|
T | 0.710 | CausalMutation | CLINVAR | Kinase-impaired BRAF mutations in lung cancer confer sensitivity to dasatinib. | 22649091 | 2012 |
|||||||
|
|
A | 0.710 | GeneticVariation | CLINVAR | NRAS and BRAF mutation frequency in primary oral mucosal melanoma. | 21750866 | 2011 |
|||||||
|
|
T | 0.710 | CausalMutation | CLINVAR | Clinical characteristics of patients with lung adenocarcinomas harboring BRAF mutations. | 21483012 | 2011 |
|||||||
|
|
T | 0.710 | CausalMutation | CLINVAR | Alterations in genes of the EGFR signaling pathway and their relationship to EGFR tyrosine kinase inhibitor sensitivity in lung cancer cell lines. | 19238210 | 2009 |
|||||||
|
|
A | 0.710 | GeneticVariation | CLINVAR | Mutational analysis of the BRAF gene in transitional cell carcinoma of the bladder. | 19404918 | 2009 |
|||||||
|
|
T | 0.710 | CausalMutation | CLINVAR | Genetic predictors of MEK dependence in non-small cell lung cancer. | 19010912 | 2008 |
|||||||
|
|
T | 0.710 | CausalMutation | CLINVAR | Mutations of the BRAF gene in human cancer. | 12068308 | 2002 |
|||||||
|
|
T | 0.710 | CausalMutation | CLINVAR | Missense mutations of the BRAF gene in human lung adenocarcinoma. | 12460919 | 2002 |
|||||||
|
|
T | 0.710 | CausalMutation | CLINVAR | BRAF and RAS mutations in human lung cancer and melanoma. | 12460918 | 2002 |